BL Pharmtech Corp.

KOSDAQ-065170
KOSDAQ
Pharmaceutical Preparations
Global Rank
#37133
Country Rank
#2371
Market Cap
16.84 M
Price
0.631
Change (%)
3.23%
Volume
103,523

BL Pharmtech Corp. (KOSDAQ-065170) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
02/26/2025 3:1 x3 x0.4462859 Forward
12/12/2024 1:10 x0.1 x0.148762 Reverse
02/05/2010 1.1:1 x1.1 x1.48762 Forward
12/29/2009 1.097:1 x1.097 x1.352382 Forward
08/05/2005 1.15:1 x1.15 x1.2328 Forward
06/23/2005 1.072:1 x1.072 x1.072 Forward

Frequently Asked Questions

  • How much would BL Pharmtech Corp. stock be worth if it never split?
    If BL Pharmtech Corp. (stock symbol: KOSDAQ-065170) had never undergone any stock splits, its price per share today would be approximately 0.28 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 3-for-1) that occurred on 02/26/2025.
  • BL Pharmtech Corp. (stock symbol: KOSDAQ-065170) has undergone a total of six stock splits. The most recent split occurred on 02/26/2025. One share bought prior to the first split on 06/23/2005 would now equal 0.45 shares.
  • BL Pharmtech Corp. (stock symbol: KOSDAQ-065170) has undergone six stock splits in its history. The most recent split, a 1.072-for-1 split, occurred on 02/26/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.